Phase 1 early drug development for oncologic indications. Practice focus on GI malignancies/melanoma.

Oncology

Anthony Olszanski practices Oncology. He went to Rutgers New Jersey Medical School. Rutgers New Jersey Medical School is ranked 76 in research and 0 in primary care medicine He over the years received 11 awards: "CMS Meaningful Use Stage 1 Certification", "Accelerating Anticancer Agent Development and Validation", "Methods in Clinical Cancer Research", "Molecular Biology in Clinical Oncology", "Awarded November 2000: PGY 6 stipend", "Deans Letter of Accommodation", "Upjohn Research Award: Perfluorochemical Research", "Smith, Kline, and French Scholarship", "University Science Foundation Scholarship", "Burroughs-Wellcome Scholarship" and "Perfluorocarbon Grant (University Grant Program)". Anthony Olszanski is also a published MD. He has 15 paper published. The most recent paper is: Autoimmune inner ear disease in a melanoma patient treated with pembrolizumab. He accepts Medicare payments and is registered with Medicare.gov.

Publications

---

• Successful Imatinib Therapy for Neuroendocrine Carcinoma With Activating KIT Mutation: A Case Study.
• Current and future roles of targeted therapy and immunotherapy in advanced Melanoma.
• Outcomes in patients with mucosal Melanomas.
• Donor transmission of Melanoma following renal transplant.
• Melanoma.
• Diastolic Blood Pressure as a Biomarker of Axitinib Efficacy in Solid Tumors.
• Phase I study of the safety, tolerability, and pharmacokinetics of Oral CP-868,596, a highly specific platelet-derived growth factor receptor tyrosine kinase inhibitor...
• Efficacy and safety of axitinib in patients with advanced non-small-cell lung Cancer: results from a phase II study.
• Phase I and pharmacokinetic study of AI-850, a novel microparticle hydrophobic drug deLivery system for paclitaxel.
• Modulation of Cell cycle progression in human tumors: a pharmacokinetic and tumor molecular pharmacodynamic study of cisplatin plus the Chk1 inhibitor UCN-01 (NSC 6388...
• Autoimmune inner ear disease in a Melanoma patient treated with pembrolizumab.
• Pharmacokinetic evaluation of axitinib.
• Phase Ib study of CP-868,596, a PDGFR inhibitor, combined with docetaxel with or without axitinib, a VEGFR inhibitor.
• Docetaxel and gemcitabine: a nonplatinum combination for non small-cell lung Cancer.

Schools

---

• UmdnjNew Jersey Medical School

Procedures Preformed

---

• Thoracentesis

Conditions Treated

---

• Adrenal Gland Cancer
• Anal and Rectal Cancer
• Anemia
• Basal Cell Carcinoma
• View All

Doctors Specialties

---

• Medical Oncology
• Oncology

Accepted Insurances

---

Awards

---

• CMS Meaningful Use Stage 1 Certification
• Accelerating Anticancer Agent Development and Validation
• Methods in Clinical Cancer Research
• Molecular Biology in Clinical Oncology
• Awarded November 2000: PGY 6 stipend
• Dean’s Letter of Accommodation
• Upjohn Research Award: Perfluorochemical Research
• Smith, Kline, and French Scholarship
• University Science Foundation Scholarship
• Burroughs-Wellcome Scholarship
• Perfluorocarbon Grant (University Grant Program)

Education

---

• Dartmouth-Hitchcock Medical Center
• Rutgers New Jersey Medical School

Hospital

---

• Fox Chase Cancer Center-American Oncologic Hospital
• Temple University Hospital

Drug Facts

---

NPI NUMBER		1447483433
NPPES Provider LastName		OLSZANSKI
NPPES Provider FirstName		ANTHONY
NPPES Provider ZIPCode		191112434
NPPES Provider State		PA
Specialty Description		Medical Oncology
Total Claim Count		283.0
Distinct Opioid Count		2.0
Opioid Claim Count		75.0
Percent Opioid Claims		26.5

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1447483433
Last Name Of The Provider	OLSZANSKI
First Name Of The Provider	ANTHONY
View All

Similar Doctors

---

	Dr. Seyfettin O. Alpdogan, MD This Doctor is OpenDoctor Recommended.
	Dr. Barbara Pro, MD This Doctor is OpenDoctor Recommended.
	Dr. Martin P. Carroll, MD This Doctor is OpenDoctor Recommended.
	Dr. Frederick G. Dold, MD This Doctor is OpenDoctor Recommended.
	Dr. Russell Schilder, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Lori J. Goldstein, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Neeta Somaiah, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Davendra P. Sohal, MD This Doctor is OpenDoctor Recommended.
	Dr. Robert L. Comis, MD This Doctor is OpenDoctor Recommended.
	Dr. Joshua M. Bauml, MD This Doctor is OpenDoctor Recommended.
	Dr. Alexander Kutikov, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog